Researchers developed a new method to predict how cancer cells evolve by gaining or losing whole chromosomes. Chromosome changes create rapid shifts that help tumors grow, adapt and resist treatment.

New research from Memorial Sloan Kettering Cancer Center (MSK) finds a potential therapeutic opportunity in regulatory T cells’ resilience to the loss of Foxp3; shows how cancer develops resistance to ...

Researchers are launching a new project to crack the mystery of aggressive breast cancer, where predicting disease progression remains a major hurdle. By studying how tumors interact with and suppress ...

Cancer doesn’t evolve by pure chaos. Scientists have developed a powerful new method that reveals the hidden rules guiding how cancer cells gain and lose whole chromosomes—massive genetic shifts that ...

Dr. Charles Sawyers, Chair of MSK's Human Oncology and Pathogenesis Program, presents during the opening plenary on how cancer cells escape targeted therapy by changing identity. Dozens of clinicians ...

Researchers in Northern Ireland and Scotland are leading a major new UK research programme designed to improve how doctors ...

Oregon Health & Science University is getting a major boost in its effort to better understand and eventually treat some of the most aggressive cancers with $6 million to research “organs-on-chips” – ...

Some of the earliest warning signs of breast cancer risk may be hidden deep within the molecular makeup of breast tissue—long before anything appears on a scan. To uncover those signals, researchers ...

EGFR-positive lung cancer is more common in non-smokers (particularly those with adenocarcinoma) and younger adults, as it often develops from a single genetic mutation rather than widespread DNA ...

Dr. Charles Sawyers, Chair of MSK's Human Oncology and Pathogenesis Program, presents during the opening plenary on how cancer cells escape targeted therapy by changing identity. Dozens of clinicians ...